Page 1

Summary of Consolidated Financial Results for the Second Quarter of the Year Ending March 31 , 2022 [ IFRS ] Company Name : Stock Exchange Listings : Security Code Number : Representative : Contact : Telephone : Filing Date of Quarterly Financial Report : Starting Date of Dividend Payments : Preparation of Supplementary Financial Data for Quarterly Financial Results : Information Meeting for Quarterly Financial Results to be held : SUMITOMO DAINIPPON PHARMA CO . , LTD . Tokyo 4506 ( URL https://www.ds-pharma.com/ ) FASE MEMBERSHIP October 27 , 2021 Hiroshi Nomura , Representative Director , President and Chief Executive Officer Atsuko Higuchi , Executive Officer , Corporate Communications 03-5159-3300 November 4 , 2021 December 1 , 2021 Yes Yes ( for institutional investors and analysts ) ( Note : All amounts are rounded to the nearest million yen ) 1. Consolidated Financial Results for the Second Quarter of the Year Ending March 31 , 2022 ( April 1 , 2021 to September 30 , 2021 ) ( 1 ) Results of Operations Revenue profit Core operating Operating profit Net profit Net profit attributable to owners of the ( % represents changes from the previous year ) Total comprehensive income parent Millions of yen % Millions of yen % Millions of yen % Millions of yen % Millions of yen % Millions of yen % Six months ended 293,730 12.3 47,919 ( 0.1 ) 47,572 0.1 29,987 ( 1.2 ) 36,450 ( 2.3 ) 2,027 ( 71.9 ) September 30 , 2021 Six months ended September 30 , 2020 261,498 13.4 47,981 7.2 47,539 ( 28.9 ) 30,339 0.0 37,297 23.0 7,223 ( 65.7 ) Reference : Profit before taxes Six months ended September 30 , 2021 : ¥ 49,266 million Six months ended September 30 , 2020 : ¥ 43,654 million " Core operating profit " is calculated by deducting from operating profit any gains and losses resulting from nonrecurring factors that the Group designates ( hereinafter referred to as “ Non - recurring Items " ) Basic earnings per share Yen Earnings per share ( diluted ) Yen Six months ended September 30 , 2021 Six months ended September 30 , 2020 ( 2 ) Financial Position As of September 30 , 2021 As of March 31 , 2021 91.75 93.88 Total assets Net assets Equity attributable to owners of the parent Millions of yen 1,267,431 1,308,127 Millions of yen 648,682 648,178 Millions of yen 582,308 580,570 Ratio of equity attributable to owners of the parent to total assets % Equity attributable to owners of the parent per share Yen 45.9 1,465.69 44.4 1,461.31